nothing new in it, however it does say that barriers to entry have broken down and Cavatak is a better bet
https://roth2.bluematrix.com/[email protected]&source=mail&pdfFileExtension=.pdf
Still says a $3.84 target
Add to My Watchlist
What is My Watchlist?